Home-Based Exercise Improves Muscle Oxidative Capacity in Kidney Disease - Kidney International Reports kireports.org/article/S2468-…
@UCDNephrology
Bob Roshanravan retweeted
In a #ASNCJASN Kidney Cross-Talk, authors explore recent evidence on Lipoprotein(a) and chronic kidney disease (CKD). Read more: kidney.pub/CJASN0968
Bob Roshanravan retweeted
Transportation insecurity negatively impacts people with end stage kidney disease (ESKD) who receive in-center dialysis, leading to missed treatments and higher mortality rates among adults without private transportation. kidney.pub/CJASN0753
#ASNCJASN
Bob Roshanravan retweeted
In a special Q&A, editors of a new #ASNCJASN series on Lifestyle Medicine and Kidney Health share more about the topic and their plans for the series: bit.ly/KN1705-17
Check out the ongoing CJASN series: journals.lww.com/asnjournals…
#ASNKidneyNews
Bob Roshanravan retweeted
Additional research on the gut-liver and gut-kidney axes is crucial for understanding their connection, with future studies exploring gut microbiota modulation through antibiotics, probiotics, prebiotics, or dietary interventions, according to a perspective in #ASNCJASN. bit.ly/CJASN0732
Bob Roshanravan retweeted
Compared to WB, PRBC perfusion is superior in mitigating post-ischemia damage and facilitating function and metabolic recovery of high-risk kidneys subjected to long CITs during a three-hour EVNP. bit.ly/KID0815
#ASNKidney360
Bob Roshanravan retweeted
Kidney disease patients experience muscle abnormalities, affecting their physical performance and leading to increased morbidity and mortality. Future research on Intermuscular Adipose Tissue (IMAT) could improve function and reduce adverse outcomes. bit.ly/CJASN0745
#ASNCJASN
Bob Roshanravan retweeted
Fun serving as a moderator for this online discussion covering updates regarding ADPKD, IgAN and FSGS; Spring Clinical Meeting 2025. medpagetoday.com/meetingcove… @nkf @edgarvlermamd @SWadhwaniMD @medpagetoday medpagetoday.com/meetingcove…
Bob Roshanravan retweeted
We’re thrilled that Dr. @marushla, one of our excellent #Nephrology faculty, has been awarded “Outstanding Instructor of the Year” by our med students! Her dedication to education & patient care exemplifies the best in medicine. We’re truly blessed to have her!
#MedEd
Bob Roshanravan retweeted
Walking training with blood flow restriction (WT-BFR) resulted in greater improvements in walking capacity than usual care in hemodialysis patients. bit.ly/CJASN0701
#ASNCJASN
Bob Roshanravan retweeted
Among diverse US Hispanic/Latino adults with CKD, higher LE8 score (better cardiovascular health) was associated with a slower decline in eGFR and lower albuminuria over six years. bit.ly/CJASN0656
#ASNCJASN
#eGFR
Bob Roshanravan retweeted
Really enjoyed putting this paper together for CJASN @asnpublications with other @GREXercise
➡️A guide to successful exercise prescriptions
➡️Understanding the barriers and facilitators
➡️Taking an activity history,
➡️How to tailor exercise ‘dose
🔗pubmed.ncbi.nlm.nih.gov/4008…
Bob Roshanravan retweeted
This study found that among Medicaid enrollees and uninsured adults with incident kidney failure, higher CHC penetration was associated with a lower prevalence of kidney disease risk factors and better preparedness for, and higher survival after, ESKD onset.
bit.ly/CJASN0598
Bob Roshanravan retweeted
Mitochondria-driven oxidative/redox stress and inflammation play a major role in CKD pathophysiology. This study found that six weeks of NR and CoQ10 improved markers of oxidative stress, inflammation, and cell bioenergetics in persons with moderate to severe CKD. bit.ly/CJASN0624
@broshan
@JLGamboa_Velez
Bob Roshanravan retweeted
Incretins are regulators of insulin secretion and glucose homeostasis metabolized by DPP-4. This study found that incretin response to oral glucose is preserved or augmented in moderate-to-severe CKD, without apparent differences in circulating DPP-4 concentration or activity. bit.ly/CJASN0566
@JLGamboa_Velez
@loggyleila
@AlpIkizler
@broshan
Bob Roshanravan retweeted
Incretins are regulators of insulin secretion and glucose homeostasis metabolized by dipeptidyl peptidase-4 (DPP-4). This study found that overall, incretin response to oral glucose is preserved or augmented in moderate to severe CKD, without apparent differences in circulating DPP-4 concentration or activity. bit.ly/CJASN0566
@alpikizler
@broshan
@JLGamboa_Velez
@loggyleila
Impaired Incretin Homeostasis in Nondiabetic... : Clinical Journal of the American Society of Nephrology journals.lww.com/cjasn/fullt…
27




















